Phosphorylation-mediated regulation of alternative splicing in cancer

International Journal of Cell Biology

Volumn , Issue , 2013, Pages

  Naro, Chiara ^a   Sette, Claudio ^a,b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AURORA A KINASE; CASPASE 9; CYCLIC AMP DEPENDENT PROTEIN KINASE; DNA TOPOISOMERASE; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; MESSENGER RNA PRECURSOR; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN TYROSINE KINASE; SERINE ARGININE RICH PROTEIN; VASCULOTROPIN A;

ALTERNATIVE RNA SPLICING; AMINO TERMINAL SEQUENCE; BINDING SITE; CATALYSIS; CELL STRESS; CELLULAR DISTRIBUTION; CONSENSUS SEQUENCE; DEPHOSPHORYLATION; ENZYME ACTIVE SITE; G2 PHASE CELL CYCLE CHECKPOINT; MITOSIS; NEOPLASM; OSMOTIC STRESS; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROCESSING; REGULATORY MECHANISM; REVIEW; RNA BINDING; SIGNAL TRANSDUCTION;

EID: 84884218346     PISSN: 16878876     EISSN: 16878884     Source Type: Journal    
DOI: 10.1155/2013/151839     Document Type: Review

References (138)

1. Barbosa-Morais N. L., Irimia M., Pan Q., The evolutionary landscape of alternative splicing in vertebrate species. Science 2012 338 6114 1587 1593
2. Sultan M., Schulz M. H., Richard H., Magen A., Klingenhoff A., Scherf M., Seifert M., Borodina T., Soldatov A., Parkhomchuk D., Schmidt D., O'Keeffe S., Haas S., Vingron M., Lehrach H., Yaspo M.-L., A global view of gene activity and alternative splicing by deep sequencing of the human transcriptome. Science 2008 321 5891 956 960 2-s2.0-47649124124 10.1126/science.1160342
3. Irimia M., Blencowe B. J., Alternative splicing: decoding an expansive regulatory layer. Current Opinion in Cell Biology 2012 24 3 323 332 10.1016/j.ceb.2012.03.005
4. Will C. L., Lührmann R., Spliceosome structure and function. Cold Spring Harbor Perspectives in Biology 2011 3 7 2-s2.0-80455144530
5. Mermoud J. E., Cohen P., Lamond A. I., Ser/Thr-specific protein phosphatases are required for both catalytic steps of pre-mRNA splicing. Nucleic Acids Research 1992 20 20 5263 5269 2-s2.0-0026731973
6. Mermoud J. E., Cohen P. T. W., Lamond A. I., Regulation of mammalian spliceosome assembly by a protein phosphorylation mechanism. EMBO Journal 1994 13 23 5679 5688 2-s2.0-0028043718
7. Mathew R., Hartmuth K., Möhlmann S., Urlaub H., Ficner R., Lührmann R., Phosphorylation of human PRP28 by SRPK2 is required for integration of the U4/U6-U5 tri-snRNP into the spliceosome. Nature Structural and Molecular Biology 2008 15 5 435 443 2-s2.0-43249109907 10.1038/nsmb.1415
8. Schneider M., Hsiao H.-H., Will C. L., Giet R., Urlaub H., Lührmann R., Human PRP4 kinase is required for stable tri-snRNP association during spliceosomal B complex formation. Nature Structural and Molecular Biology 2010 17 2 216 221 2-s2.0-76349122915 10.1038/nsmb.1718
9. Shi Y., Reddy B., Manley J. L., PP1/PP2A phosphatases are required for the second step of Pre-mRNA splicing and target specific snRNP proteins. Molecular Cell 2006 23 6 819 829 2-s2.0-33748415171 10.1016/j.molcel.2006.07.022
10. Tanuma N., Kim S.-E., Beullens M., Tsubaki Y., Mitsuhashi S., Nomura M., Kawamura T., Isono K., Koseki H., Sato M., Bollen M., Kikuchi K., Shima H., Nuclear inhibitor of protein phosphatase-1 (NIPP1) directs protein phosphatase-1 (PP1) to dephosphorylate the U2 small nuclear ribonucleoprotein particle (snRNP) component, spliceosome-associated protein 155 (Sap155). Journal of Biological Chemistry 2008 283 51 35805 35814 2-s2.0-58149096435 10.1074/jbc.M805468200
11. Manceau V., Swenson M., Le Caer J.-P., Sobel A., Kielkopf C. L., Maucuer A., Major phosphorylation of SF1 on adjacent Ser-Pro motifs enhances interaction with U2AF65. FEBS Journal 2006 273 3 577 587 2-s2.0-33644944537 10.1111/j.1742-4658.2005.05091.x
12. Cho S., Hoang A., Sinha R., Zhong X.-Y., Fu X.-D., Krainer A. R., Ghosh G., Interaction between the RNA binding domains of Ser-Arg splicing factor 1 and U1-70K snRNP protein determines early spliceosome assembly. Proceedings of the National Academy of Sciences of the United States of America 2011 108 20 8233 8238 2-s2.0-79957784833 10.1073/pnas.1017700108
13. Prasad J., Colwill K., Pawson T., Manley J. L., The protein kinase Clk/Sty directly modulates SR protein activity: both hyper- and hypophosphorylation inhibit splicing. Molecular and Cellular Biology 1999 19 10 6991 7000 2-s2.0-0032827418
14. Cao W., Jamison S. F., Garcia-Blanco M. A., Both phosphorylation and dephosphorylation of ASF/SF2 are required for pre-mRNA splicing in vitro. RNA 1997 3 12 1456 1467 2-s2.0-0031468240
15. Tacke R., Chen Y., Manley J. L., Sequence-specific RNA binding by an SR protein requires RS domain phosphorylation: creation of an SRp40-specific splicing enhancer. Proceedings of the National Academy of Sciences of the United States of America 1997 94 4 1148 1153 2-s2.0-0031037690 10.1073/pnas.94.4.1148
16. Feng Y., Chen M., Manley J. L., Phosphorylation switches the general splicing repressor SRp38 to a sequence-specific activator. Nature Structural and Molecular Biology 2008 15 10 1040 1048 2-s2.0-53549089314 10.1038/nsmb.1485
17. Shin C., Manley J. L., The SR protein SRp38 represses splicing in M phase cells. Cell 2002 111 3 407 417 2-s2.0-0036848091 10.1016/S0092-8674(02)01038-3
18. Shin C., Feng Y., Manley J. L., Dephosphorylated SRp38 acts as a splicing repressor in response to heat shock. Nature 2004 427 6974 553 558 2-s2.0-1142310938 10.1038/nature02288
19. Shi Y., Manley J. L., A complex signaling pathway regulates SRp38 phosphorylation and pre-mRNA splicing in response to heat shock. Molecular Cell 2007 28 1 79 90 2-s2.0-34948892099 10.1016/j.molcel.2007.08.028
20. Spector D. L., Lamond A. I., Nuclear speckles. Cold Spring Harbor Perspectives in Biology 2011 3 2 2-s2.0-79960621734
21. Misteli T., Cáceres J. F., Clement J. Q., Krainer A. R., Wilkinson M. F., Spector D. L., Serine phosphorylation of SR proteins is required for their recruitment to sites of transcription in vivo. Journal of Cell Biology 1998 143 2 297 307 2-s2.0-0032547829 10.1083/jcb.143.2.297
22. Lai M.-C., Lin R.-I., Tarn W.-Y., Transportin-SR2 mediates nuclear import of phosphorylated SR proteins. Proceedings of the National Academy of Sciences of the United States of America 2001 98 18 10154 10159 2-s2.0-0035964258 10.1073/pnas.181354098
23. Lin S., Xiao R., Sun P., Xu X., Fu X.-D., Dephosphorylation-dependent sorting of SR splicing factors during mRNP maturation. Molecular Cell 2005 20 3 413 425 2-s2.0-27644592554 10.1016/j.molcel.2005.09.015
24. Huang Y., Yario T. A., Steitz J. A., A molecular link between SR protein dephosphorylation and mRNA export. Proceedings of the National Academy of Sciences of the United States of America 2004 101 26 9666 9670 2-s2.0-3042836378 10.1073/pnas.0403533101
25. Lai M.-C., Tarn W.-Y., Hypophosphorylated ASF/SF2 binds TAP and is present in messenger ribonucleoproteins. Journal of Biological Chemistry 2004 279 30 31745 31749 2-s2.0-3843075319 10.1074/jbc.C400173200
26. Sanford J. R., Ellis J. D., Cazalla D., Cáceres J. F., Reversible phosphorylation differentially affects nuclear and cytoplasmic functions of splicing factor 2/alternative splicing factor. Proceedings of the National Academy of Sciences of the United States of America 2005 102 42 15042 15047 2-s2.0-27244441805 10.1073/pnas.0507827102
27. Zhong X.-Y., Wang P., Han J., Rosenfeld M. G., Fu X.-D., SR proteins in vertical integration of gene expression from transcription to RNA processing to translation. Molecular Cell 2009 35 1 1 10 2-s2.0-67649671966 10.1016/j.molcel.2009.06.016
28. Van Oordt W. V. D. H., Diaz-Meco M. T., Lozano J., Krainer A. R., Moscat J., Cáceres J. F., The MKK(3/6)-p38-signaling cascade alters the subcellular distribution of hnRNP A1 and modulates alternative splicing regulation. Journal of Cell Biology 2000 149 2 307 316 2-s2.0-0007570010 10.1083/jcb.149.2.307
29. Guil S., Long J. C., Cáceres J. F., hnRNP A1 relocalization to the stress granules reflects a role in the stress response. Molecular and Cellular Biology 2006 26 15 5744 5758 2-s2.0-33746516731 10.1128/MCB.00224-06
30. Stoilov P., Dauod R., Nayler O., Stamm S., Human tra2-beta1 autoregulates its protein concentration by infuencing alternative splicing of its pre-mRNA. Human Molecular Genetics 2004 13 5 509 524 2-s2.0-1542359466 10.1093/hmg/ddh051
31. Goehe R. W., Shultz J. C., Murudkar C., Usanovic S., Lamour N. F., Massey D. H., Zhang L., Camidge D. R., Shay J. W., Minna J. D., Chalfant C. E., hnRNP L regulates the tumorigenic capacity of lung cancer xenografts in mice via caspase-9 pre-mRNA processing. Journal of Clinical Investigation 2010 120 11 3923 3939 2-s2.0-78049448047 10.1172/JCI43552
32. Liu G., Razanau A., Hai Y., Yu J., Sohail M., Lobo V. G., Chu J., Kung S. K., Xie J., A conserved serine of heterogeneous nuclear ribonucleoprotein L (hnRNP L) mediates depolarization-regulated alternative splicing of potassium channels. The Journal of Biological Chemistry 2012 287 27 22709 22716
33. Sette C., Post-translational regulation of star proteins and effects on their biological functions. Advances in Experimental Medicine and Biology 2010 693 54 66 2-s2.0-79952199620 10.1007/978-1-4419-7005-3-4
34. Lukong K. E., Larocque D., Tyner A. L., Richard S., Tyrosine phosphorylation of Sam68 by breast tumor kinase regulates intranuclear localization and cell cycle progression. Journal of Biological Chemistry 2005 280 46 38639 38647 2-s2.0-33644663231 10.1074/jbc.M505802200
35. Paronetto M. P., Achsel T., Massiello A., Chalfant C. E., Sette C., The RNA-binding protein Sam68 modulates the alternative splicing of Bcl-x. Journal of Cell Biology 2007 176 7 929 939 2-s2.0-33947712084 10.1083/jcb.200701005
36. Matter N., Herrlich P., König H., Signal-dependent regulation of splicing via phosphorylation of Sam68. Nature 2002 420 6916 691 695 2-s2.0-0037069651 10.1038/nature01153
37. Cheng C., Sharp P. A., Regulation of CD44 alternative splicing by SRm160 and its potential role in tumor cell invasion. Molecular and Cellular Biology 2006 26 1 362 370 2-s2.0-33645220093 10.1128/MCB.26.1.362-370.2006
38. Paronetto M. P., Cappellari M., Busà R., Pedrotti S., Vitali R., Comstock C., Hyslop T., Knudsen K. E., Sette C., Alternative splicing of the cyclin D1 proto-oncogene is regulated by the RNA-binding protein Sam68. Cancer Research 2010 70 1 229 239 2-s2.0-75149187424 10.1158/0008-5472.CAN-09-2788
39. Gui J.-F., Lane W. S., Fu X.-D., A serine kinase regulates intracellular localization of splicing factors in the cell cycle. Nature 1994 369 6482 678 682 2-s2.0-0028286596 10.1038/369678a0
40. Ghosh G., Adams J. A., Phosphorylation mechanism and structure of serine-arginine protein kinases. FEBS Journal 2011 278 4 587 597 2-s2.0-79751504755 10.1111/j.1742-4658.2010.07992.x
41. Ding J.-H., Zhong X.-Y., Hagopian J. C., Cruz M. M., Ghosh G., Feramisco J., Adams J. A., Fu X.-D., Regulated cellular partitioning of SR protein-specific kinases in mammalian cells. Molecular Biology of the Cell 2006 17 2 876 885 2-s2.0-31944432341 10.1091/mbc.E05-10-0963
42. Zhong X.-Y., Ding J.-H., Adams J. A., Ghosh G., Fu X.-D., Regulation of SR protein phosphorylation and alternative splicing by modulating kinetic interactions of SRPK1 with molecular chaperones. Genes and Development 2009 23 4 482 495 2-s2.0-61449176062 10.1101/gad.1752109
43. Zhou Z., Qiu J., Liu W., The Akt-SRPK-SR axis constitutes a major pathway in transducing EGF signaling to regulate alternative splicing in the nucleus. Molecular Cell 2012 47 3 422 433
44. Yun C. Y., Fu X.-D., Conserved SR protein kinase functions in nuclear import and its action is counteracted by arginine methylation in Saccharomyces cerevisiae. Journal of Cell Biology 2000 150 4 707 717 2-s2.0-0034698665 10.1083/jcb.150.4.707
45. Yun C. Y., Velazquez-Dones A. L., Lyman S. K., Fu X.-D., Phosphorylation-dependent and -independent nuclear import of RS domain-containing splicing factors and regulators. Journal of Biological Chemistry 2003 278 20 18050 18055 2-s2.0-0038043222 10.1074/jbc.M211714200
46. Wang H.-Y., Lin W., Dyck J. A., Yeakley J. M., Songyang Z., Cantley L. C., Fu X.-D., SRPK2: a differentially expressed SR protein-specific kinase involved in mediating the interaction and localization of pre-mRNA splicing factors in mammalian cells. Journal of Cell Biology 1998 140 4 737 750 2-s2.0-0032559642 10.1083/jcb.140.4.737
47. Nowak D. G., Amin E. M., Rennel E. S., Hoareau-Aveilla C., Gammons M., Damodoran G., Hagiwara M., Harper S. J., Woolard J., Ladomery M. R., Bates D. O., Regulation of Vascular Endothelial Growth Factor (VEGF) splicing from pro-angiogenic to anti-angiogenic isoforms: a novel therapeutic strategy for angiogenesis. Journal of Biological Chemistry 2010 285 8 5532 5540 2-s2.0-77949318969 10.1074/jbc.M109.074930
48. Amin E. M., Oltean S., Hua J., Gammons M. V. R., Hamdollah-Zadeh M., Welsh G. I., Cheung M.-K., Ni L., Kase S., Rennel E. S., Symonds K. E., Nowak D. G., Royer-Pokora B., Saleem M. A., Hagiwara M., Schumacher V. A., Harper S. J., Hinton D. R., Bates D. O., Ladomery M. R., WT1 mutants reveal SRPK1 to be a downstream angiogenesis target by altering VEGF splicing. Cancer Cell 2011 20 6 768 780 2-s2.0-83455263848 10.1016/j.ccr.2011.10.016
49. Colwill K., Pawson T., Andrews B., Prasad J., Manley J. L., Bell J. C., Duncan P. I., The Clk/Sty protein kinase phosphorylates SR splicing factors and regulates their intranuclear distribution. EMBO Journal 1996 15 2 265 275 2-s2.0-0030028882
50. Duncan P. I., Stojdl D. F., Marius R. M., Bell J. C., In vivo regulation of alternative pre-mRNA splicing by the Clk1 protein kinase. Molecular and Cellular Biology 1997 17 10 5996 6001 2-s2.0-0030863326
51. Hartmann A. M., Rujescu D., Giannakouros T., Nikolakaki E., Goedert M., Mandelkow E.-M., Gao Q. S., Andreadis A., Stamm S., Regulation of alternative splicing of human tau exon 10 by phosphorylation of splicing factors. Molecular and Cellular Neuroscience 2001 18 1 80 90 2-s2.0-0034916318 10.1006/mcne.2001. 1000
52. Liu Y., Conaway L., Rutherford Bethard J., Al-Ayoubi A. M., Thompson Bradley A., Zheng H., Weed S. A., Eblen S. T., Phosphorylation of the alternative mRNA splicing factor 45 (SPF45) by Clk1 regulates its splice site utilization, cell migration and invasion. Nucleic Acids Research 2013 41 9 4949 4962
53. Ngo J. C. K., Chakrabarti S., Ding J.-H., Velazquez-Dones A., Nolen B., Aubol B. E., Adams J. A., Fu X.-D., Ghosh G., Interplay between SRPK and Clk/Sty kinases in phosphorylation of the splicing factor ASF/SF2 is regulated by a docking motif in ASF/SF2. Molecular Cell 2005 20 1 77 89 2-s2.0-25844491145 10.1016/j.molcel.2005.08.025
54. Colwill K., Feng L. L., Yeakley J. M., Gish G. D., Cácereso J. F., Pawson T., Fu X.-D., SRPK1 and Clk/Sty protein kinases show distinct substrate specificities for serine/arginine-rich splicing factors. Journal of Biological Chemistry 1996 271 40 24569 24575 2-s2.0-0029744344 10.1074/jbc.271.40.24569
55. Nowak D. G., Woolard J., Amin E. M., Konopatskaya O., Saleem M. A., Churchill A. J., Ladomery M. R., Harper S. J., Bates D. O., Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors. Journal of Cell Science 2008 121 20 3487 3495 2-s2.0-56349136033 10.1242/jcs.016410
56. Franke T. F., PI3K/Akt: getting it right matters. Oncogene 2008 27 50 6473 6488 2-s2.0-54949109808 10.1038/onc.2008.313
57. Obata T., Yaffe M. B., Leparc G. G., Piro E. T., Maegawa H., Kashiwagi A., Kikkawa R., Cantley L. C., Peptide and protein library screening defines optimal substrate motifs for AKT/PKB. Journal of Biological Chemistry 2000 275 46 36108 36115 2-s2.0-0034680838 10.1074/jbc.M005497200
58. Vu N. T., Park M. A., Shultz J. C., Goehe R. W., Hoeferlin L. A., Shultz M. D., Smith S. A., Lynch K. W., Chalfant C. E., hnRNP U enhances caspase-9 splicing and is modulated by AKT-dependent phosphorylation of hnRNP L. The Journal of Biological Chemistry 2013 288 12 8575 8584
59. Jo O. D., Martin J., Bernath A., Masri J., Lichtenstein A., Gera J., Heterogeneous nuclear ribonucleoprotein A1 regulates cyclin D1 and c-myc internal ribosome entry site function through Akt signaling. Journal of Biological Chemistry 2008 283 34 23274 23287 2-s2.0-53149153190 10.1074/jbc.M801185200
60. Blaustein M., Pelisch F., Tanos T., Muñoz M. J., Wengier D., Quadrana L., Sanford J. R., Muschietti J. P., Kornblihtt A. R., Cáceres J. F., Coso O. A., Srebrow A., Concerted regulation of nuclear and cytoplasmic activities of SR proteins by AKT. Nature Structural and Molecular Biology 2005 12 12 1037 1044 2-s2.0-28544450763 10.1038/nsmb1020
61. Chalfant C. E., Mischak H., Watson J. E., Winkler B. C., Goodnight J., Farese R. V., Cooper D. R., Regulation of alternative splicing of protein kinase C β by insulin. Journal of Biological Chemistry 1995 270 22 13326 13332 2-s2.0-0029060644 10.1074/jbc.270.22.13326
62. Patel N. A., Chalfant C. E., Watson J. E., Wyatt J. R., Dean N. M., Eichler D. C., Cooper D. R., Insulin regulates alternative splicing of protein kinase C beta II through a phosphatidylinositol 3-kinase-dependent pathway involving the nuclear serine/arginine-rich splicing factor, SRp40, in skeletal muscle cells. Journal of Biological Chemistry 2001 276 25 22648 22654 2-s2.0-0035933893 10.1074/jbc.M101260200
63. Patel N. A., Kaneko S., Apostolatos H. S., Sun S. B., Watson J. E., Davidowitz K., Chappell D. S., Birnbaum M. J., Cheng J. Q., Cooper D. R., Molecular and genetic studies imply Akt-mediated signaling promotes protein kinase C β II alternative splicing via phosphorylation of serine/arginine-rich splicing factor SRp40. Journal of Biological Chemistry 2005 280 14 14302 14309 2-s2.0-20244372405 10.1074/jbc.M411485200
64. Jiang K., Patel N. A., Watson J. E., Apostolatos H., Kleiman E., Hanson O., Hagiwara M., Cooper D. R., Akt2 regulation of Cdc2-like kinases (Clk/Sty), serine/arginine-rich (SR) protein phosphorylation, and insulin-induced alternative splicing of PKC β JII messenger ribonucleic acid. Endocrinology 2009 150 5 2087 2097 2-s2.0-66449111724 10.1210/en.2008-0818
65. Li P., Carter G., Romero J., Gower K. M., Watson J., Patel N. A., Cooper D. R., Clk/STY (cdc2-like kinase 1) and Akt regulate alternative splicing and adipogenesis in 3T3-L1 pre-adipocytes. PLoS ONE 2013 8 1 e53268
66. Cargnello M., Roux P. P., Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiology and Molecular Biology Reviews 2011 75 1 50 83 2-s2.0-79952435349 10.1128/MMBR.00031-10
67. Ponta H., Sherman L., Herrlich P. A., CD44: from adhesion molecules to signalling regulators. Nature Reviews Molecular Cell Biology 2003 4 1 33 45 2-s2.0-0037227965 10.1038/nrm1004
68. Weg-Remers S., Ponta H., Herrlich P., König H., Regulation of alternative pre-mRNA splicing by the ERK MAP-kinase pathway. EMBO Journal 2001 20 15 4194 4203 2-s2.0-0035421277 10.1093/emboj/20.15.4194
69. Tisserant A., König H., Signal-regulated pre-mRNA occupancy by the general splicing factor U2AF. PLoS ONE 2008 3 1 2-s2.0-38949098164 10.1371/journal.pone.0001418 e1418
70. Al-Ayoubi A. M., Zheng H., Liu Y., Bai T., Eblen S. T., Mitogen-activated protein kinase phosphorylation of splicing factor 45 (SPF45) regulates SPF45 alternative splicing site utilization, proliferation, and cell adhesion. Molecular and Cellular Biology 2012 32 14 2880 2893
71. Allemand E., Guil S., Myers M., Moscat J., Cáceres J. F., Krainer A. R., Regulation of heterogenous nuclear ribonucleoprotein A1 transport by phosphorylation in cells stressed by osmotic shock. Proceedings of the National Academy of Sciences of the United States of America 2005 102 10 3605 3610 2-s2.0-14844367002 10.1073/pnas.0409889102
72. Buxadé M., Parra J. L., Rousseau S., Shpiro N., Marquez R., Morrice N., Bain J., Espel E., Proud C. G., The Mnks are novel components in the control of TNF α biosynthesis and phosphorylate and regulate hnRNP A1. Immunity 2005 23 2 177 189 2-s2.0-23844516065 10.1016/j.immuni.2005.06.009
73. Derry J. J., Richard S., Carvajal H. V., Ye X., Vasioukhin V., Cochrane A. W., Chen T., Tyner A. L., Sik (BRK) phosphorylates sam68 in the nucleus and negatively regulates Its RNA binding ability. Molecular and Cellular Biology 2000 20 16 6114 6126 2-s2.0-0033852593 10.1128/MCB.20.16.6114-6126.2000
74. Haegebarth A., Heap D., Bie W., Derry J. J., Richard S., Tyner A. L., The nuclear tyrosine kinase BRK/Sik phosphorylates and inhibits the RNA-binding activities of the Sam68-like mammalian proteins SLM-1 and SLM-2. Journal of Biological Chemistry 2004 279 52 54398 54404 2-s2.0-11144245896 10.1074/jbc.M409579200
75. Hartmann A. M., Nayler O., Schwaiger F. W., Obermeier A., Stamm S., The interaction and colocalization of Sam68 with the splicing-associated factor YT521-B in nuclear dots is regulated by the Src family kinase p59(fyn). Molecular Biology of the Cell 1999 10 11 3909 3926 2-s2.0-0032739144
76. Rafalska I., Zhang Z., Benderska N., Wolff H., Hartmann A. M., Brack-Werner R., Stamm S., The intranuclear localization and function of YT521-B is regulated by tyrosine phosphorylation. Human Molecular Genetics 2004 13 15 1535 1549 2-s2.0-4344686893 10.1093/hmg/ddh167
77. Sassone-Corsi P., The cyclic AMP pathway. Cold Spring Harbor Perspectives in Biology 2012 4 12
78. Kvissel A.-K., Ørstavik S., Eikvar S., Brede G., Jahnsen T., Collas P., Akusjärvi G., Skålhegg B. S., Involvement of the catalytic subunit of protein kinase A and of HA95 in pre-mRNA splicing. Experimental Cell Research 2007 313 13 2795 2809 2-s2.0-34547166984 10.1016/j.yexcr.2007.05.014
79. Jarnæss E., Stokka A. J., Kvissel A.-K., Skålhegg B. S., Torgersen K. M., Scott J. D., Carlson C. R., Taskén K., Splicing factor arginine/serine-rich 17A (SFRS17A) is an A-kinase anchoring protein that targets protein kinase A to splicing factor compartments. Journal of Biological Chemistry 2009 284 50 35154 35164 2-s2.0-71749090246 10.1074/jbc.M109.056465
80. Shi J., Qian W., Yin X., Iqbal K., Grundke-Iqbal I., Gu X., Ding F., Gong C.-X., Liu F., Cyclic AMP-dependent protein kinase regulates the alternative splicing of tau exon 10: a mechanism involved in tau pathology of Alzheimer disease. Journal of Biological Chemistry 2011 286 16 14639 14648 2-s2.0-79954583408 10.1074/jbc.M110.204453
81. Gu J., Shi J., Wu S., Cyclic AMP-dependent protein kinase regulates 9G8-mediated alternative splicing of tau exon 10. FEBS Letters 2012 586 16 2239 2244
82. Cao W., Razanau A., Feng D., Lobo V. G., Xie J., Control of alternative splicing by forskolin through hnRNP K during neuronal differentiation. Nucleic Acids Research 2012 40 16 8059 8071
83. Zheng S., Black D. L., Alternative pre-mRNA splicing in neurons: growing up and extending its reach. Trends in Genetics 2013 29 8 442 448
84. Wang J. C., Cellular roles of DNA topoisomerases: a molecular perspective. Nature Reviews Molecular Cell Biology 2002 3 6 430 440 2-s2.0-0036085460 10.1038/nrm831
85. Labourier E., Rossi F., Gallouzi I.-E., Allemand E., Divita G., Tazi J., Interaction between the N-terminal domain of human DNA topoisomerase I and the arginine-serine domain of its substrate determines phosphorylation of SF2/ASF splicing factor. Nucleic Acids Research 1998 26 12 2955 2962 2-s2.0-0032526604 10.1093/nar/26.12.2955
86. Soret J., Gabut M., Dupon C., Kohlhagen G., Stévenin J., Pommier Y., Tazi J., Altered serine/arginine-rich protein phosphorylation and exonic enhancer-dependent splicing in Mammalian cells lacking topoisomerase I. Cancer Research 2003 63 23 8203 8211 2-s2.0-0346365373
87. Pilch B., Allemand E., Facompré M., Bailly C., Riou J.-F., Soret J., Tazi J., Specific inhibition of serine- and arginine-rich splicing factors phosphorylation, spliceosome assembly, and splicing by the antitumor drug NB-506. Cancer Research 2001 61 18 6876 6884 2-s2.0-0035884180
88. Malanga M., Czubaty A., Girstun A., Staron K., Althaus F. R., Poly(ADP-ribose) binds to the splicing factor ASF/SF2 and regulates its phosphorylation by DNA topoisomerase I. Journal of Biological Chemistry 2008 283 29 19991 19998 2-s2.0-50649093361 10.1074/jbc.M709495200
89. Tejedor F. J., Hämmerle B., MNB/DYRK1A as a multiple regulator of neuronal development. FEBS Journal 2011 278 2 223 235 2-s2.0-78651062069 10.1111/j.1742-4658.2010.07954.x
90. Álvarez M., Estivill X., de la Luna S., DYRK1A accumulates in splicing speckles through a novel targeting signal and induces speckle disassembly. Journal of Cell Science 2003 116 15 3099 3107 2-s2.0-0041885252 10.1242/jcs.00618
91. Shi J., Zhang T., Zhou C., Chohan M. O., Gu X., Wegiel J., Zhou J., Hwang Y.-W., Iqbal K., Grundke-Iqbal I., Gong C.-X., Liu F., Increased dosage of Dyrk1A alters alternative splicing factor (ASF)-regulated alternative splicing of tau in down syndrome. Journal of Biological Chemistry 2008 283 42 28660 28669 2-s2.0-57649134248 10.1074/jbc.M802645200
92. Ding S., Shi J., Qian W., Iqbal K., Grundke-Iqbal I., Gong C.-X., Liu F., Regulation of alternative splicing of tau exon 10 by 9G8 and Dyrk1A. Neurobiology of Aging 2011 2-s2.0-78650785580 10.1016/j.neurobiolaging.2010.11. 021
93. Qian W., Liang H., Shi J., Jin N., Grundke-Iqbal I., Iqbal K., Gong C.-X., Liu F., Regulation of the alternative splicing of tau exon 10 by SC35 and Dyrk1A. Nucleic Acids Research 2011 39 14 6161 6171 2-s2.0-80051737020 10.1093/nar/gkr195
94. Yin X., Jin N., Gu J., Dual-specificity tyrosine phosphorylation- regulated kinase 1A (Dyrk1A) modulates serine/arginine-rich protein 55 (SRp55)-promoted Tau exon 10 inclusion. The Journal of Biological Chemistry 2012 287 36 30497 30506
95. Tian Q., Taupin J.-L., Elledge S., Robertson M., Anderson P., Fas-activated serine/threonine kinase (FAST) phosphorylates TIA-1 during Fas-mediated apoptosis. Journal of Experimental Medicine 1995 182 3 865 874 2-s2.0-0029126581 10.1084/jem.182.3.865
96. Izquierdo J. M., Valcárcel J., Fas-activated Serine/Threonine Kinase (FAST K) synergizes with TIA-1/TIAR proteins to regulate Fas alternative splicing. Journal of Biological Chemistry 2007 282 3 1539 1543 2-s2.0-33847308702 10.1074/jbc.C600198200
97. Simarro M., Mauger D., Rhee K., Pujana M. A., Kedersha N. L., Yamasaki S., Cusick M. E., Vidal M., Garcia-Blanco M. A., Anderson P., Fas-activated serine/threonine phosphoprotein (FAST) is a regulator of alternative splicing. Proceedings of the National Academy of Sciences of the United States of America 2007 104 27 11370 11375 2-s2.0-34547482869 10.1073/pnas.0704964104
98. Moore M. J., Wang Q., Kennedy C. J., Silver P. A., An alternative splicing network links cell-cycle control to apoptosis. Cell 2010 142 4 625 636 2-s2.0-77955662560 10.1016/j.cell.2010.07.019
99. Reiter R., Gais P., Jutting U., Steuer-Vogt M. K., Pickhard A., Bink K., Rauser S., Lassmann S., Höfler H., Werner M., Walch A., Aurora kinase A messenger RNA overexpression is correlated with tumor progression and shortened survival in head and neck squamous cell carcinoma. Clinical Cancer Research 2006 12 17 5136 5141 2-s2.0-33748991178 10.1158/1078-0432.CCR-05-1650
100. Cooper T. A., Wan L., Dreyfuss G., RNA and disease. Cell 2009 136 4 777 793
101. Andreadis A., Tau splicing and the intricacies of dementia. Journal of Cellular Physiology 2012 227 3 1220 1225 2-s2.0-80054990959 10.1002/jcp.22842
102. Glatz D. C., Rujescu D., Tang Y., Berendt F. J., Hartmann A. M., Faltraco F., Rosenberg C., Hulette C., Jellinger K., Hampel H., Riederer P., Möller H.-J., Andreadis A., Henkel K., Stamm S., The alternative splicing of tau exon 10 and its regulatory proteins CLK2 and TRA2-BETA1 changes in sporadic Alzheimer's disease. Journal of Neurochemistry 2006 96 3 635 644 2-s2.0-33645107783 10.1111/j.1471-4159.2005.03552.x
103. Liang Z., Liu F., Grundke-Iqbal I., Iqbal K., Gong C.-X., Down-regulation of cAMP-dependent protein kinase by over-activated calpain in Alzheimer disease brain. Journal of Neurochemistry 2007 103 6 2462 2470 2-s2.0-36448978859 10.1111/j.1471-4159.2007.04942.x
104. Zhou J., Yu Q., Zou T., Alternative splicing of exon 10 in the tau gene as a target for treatment of tauopathies. BMC Neuroscience 2008 9 2, article S10 2-s2.0-57449118452 10.1186/1471-2202-9-S2-S10
105. Hayes G. M., Carrigan P. E., Beck A. M., Miller L. J., Targeting the RNA splicing machinery as a novel treatment strategy for pancreatic carcinoma. Cancer Research 2006 66 7 3819 3827 2-s2.0-33645746620 10.1158/0008-5472.CAN-05- 4065
106. Hayes G. M., Carrigan P. E., Miller L. J., Serine-arginine protein kinase 1 overexpression is associated with tumorigenic imbalance in mitogen-activated protein kinase pathways in breast, colonic, and pancreatic carcinomas. Cancer Research 2007 67 5 2072 2080 2-s2.0-33947223157 10.1158/0008-5472.CAN-06-2969
107. Gout S., Brambilla E., Boudria A., Drissi R., Lantuejoul S., Gazzeri E., Eymin B., Abnormal expression of the pre-mRNA splicing regulators SRSF1, SRSF2, SRPK1 and SRPK2 in non-small cell lung carcinoma. PLoS ONE 2012 7 10 e46539
108. Odunsi K., Mhawech-Fauceglia P., Andrews C., Elevated expression of the serine-arginine protein kinase 1 gene in ovarian cancer and its role in Cisplatin cytotoxicity in vitro. PLoS ONE 2012 7 12
109. Adesso L., Calabretta S., Barbagallo F., Gemcitabine triggers a pro-survival response in pancreatic cancer cells through activation of the MNK2/eIF4E pathway. Oncogene 2013 32 23 2848 2857
110. Locatelli A., Lange C. A., Met receptors induce Sam68-dependent cell migration by activation of alternate extracellular signal-regulated kinase family members. Journal of Biological Chemistry 2011 286 24 21062 21072 2-s2.0-79958699176 10.1074/jbc.M110.211409
111. Ghigna C., Giordano S., Shen H., Benvenuto F., Castiglioni F., Comoglio P. M., Green M. R., Riva S., Biamonti G., Cell motility is controlled by SF2/ASF through alternative splicing of the Ron protooncogene. Molecular Cell 2005 20 6 881 890 2-s2.0-29144447982 10.1016/j.molcel.2005.10.026
112. Valacca C., Bonomi S., Buratti E., Pedrotti S., Baralle F. E., Sette C., Ghigna C., Biamonti G., Sam68 regulates EMT through alternative splicing-activated nonsense-mediated mRNA decay of the SF2/ASF proto-oncogene. Journal of Cell Biology 2010 191 1 87 99 2-s2.0-77957726684 10.1083/jcb. 201001073
113. Yea S., Narla G., Zhao X., Garg R., Tal-Kremer S., Hod E., Villanueva A., Loke J., Tarocchi M., Akita K., Shirasawa S., Sasazuki T., Martignetti J. A., Llovet J. M., Friedman S. L., Ras promotes growth by alternative splicing-mediated inactivation of the KLF6 tumor suppressor in hepatocellular carcinoma. Gastroenterology 2008 134 5 1521 1531 2-s2.0-42949176197 10.1053/j.gastro.2008.02.015
114. Shultz J. C., Goehe R. W., Wijesinghe D. S., Murudkar C., Hawkins A. J., Shay J. W., Minna J. D., Chalfant C. E., Alternative splicing of caspase 9 is modulated by the phosphoinositide 3-kinase/Akt pathway via phosphorylation of SRp30a. Cancer Research 2010 70 22 9185 9196 2-s2.0-78549234102 10.1158/0008-5472.CAN-10-1545
115. Trinkle-Mulcahy L., Ajuh P., Prescott A., Claverie-Martin F., Cohen S., Lamond A. I., Cohen P., Nuclear organisation of NIPP1, a regulatory subunit of protein phosphatase 1 that associates with pre-mRNA splicing factors. Journal of Cell Science 1999 112 2 157 168 2-s2.0-0032994412
116. Boudrez A., Beullens M., Groenen P., Van Eynde A., Vulsteke V., Jagiello I., Murray M., Krainer A. R., Stalmans W., Bollen M., NIPP1-mediated interaction of protein phosphatase-1 with CDC5L, a regulator of pre-mRNA splicing and mitotic entry. Journal of Biological Chemistry 2000 275 33 25411 25417 2-s2.0-0034682811 10.1074/jbc.M001676200
117. Boudrez A., Beullens M., Waelkens E., Stalmans W., Bollen M., Phosphorylation-dependent interaction between the splicing factors SAP155 and NIPP1. Journal of Biological Chemistry 2002 277 35 31834 31841 2-s2.0-0037200062 10.1074/jbc.M204427200
118. Murray M. V., Kobayashi R., Krainer A. R., The type 2C Ser/Thr phosphatase PP2C γ is a pre-mRNA splicing factor. Genes and Development 1999 13 1 87 97 2-s2.0-0032901297
119. Cardinali B., Cohen P. T. W., Lamond A. I., Protein phosphatase 1 can modulate alternative 5′ splice site selection in a HeLa splicing extract. FEBS Letters 1994 352 3 276 280 2-s2.0-0027998643 10.1016/0014-5793(94)00973-2
120. Allemand E., Hastings M. L., Murray M. V., Myers M. P., Krainer A. R., Alternative splicing regulation by interaction of phosphatase PP2C γ with nucleic acid-binding protein YB-1. Nature Structural and Molecular Biology 2007 14 7 630 638 2-s2.0-34447115759 10.1038/nsmb1257
121. Novoyatleva T., Heinrich B., Tang Y., Benderska N., Butchbach M. E. R., Lorson C. L., Lorson M. A., Ben-Dov C., Fehlbaum P., Bracco L., Burghes A. H. M., Bollen M., Stamm S., Protein phosphatase 1 binds to the RNA recognition motif of several splicing factors and regulates alternative pre-mRNA processing. Human Molecular Genetics 2008 17 1 52 70 2-s2.0-37549002103 10.1093/hmg/ddm284
122. Lorson C. L., Hahnen E., Androphy E. J., Wirth B., A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proceedings of the National Academy of Sciences of the United States of America 1999 96 11 6307 6311 2-s2.0-0033033434 10.1073/pnas.96.11.6307
123. Zhang Z., Kelemen O., Van Santen M. A., Yelton S. M., Wendlandt A. E.,
124. Chalfant C. E., Rathman K., Pinkerman R. L., Wood R. E., Obeid L. M., Ogretmen B., Hannun Y. A., De novo ceramide regulates the alternative splicing of caspase 9 and Bcl-x in A549 lung adenocarcinoma cells. Dependence on protein phosphatase-1. Journal of Biological Chemistry 2002 277 15 12587 12595 2-s2.0-0037066727 10.1074/jbc.M112010200
125. Sumanasekera C., Kelemen O., Beullens M., C6 pyridinium ceramide influences alternative pre-mRNA splicing by inhibiting protein phosphatase-1. Nucleic Acids Research 2012 40 9 4025 4039
126. Venables J. P., Klinck R., Bramard A., Inkel L., Dufresne-Martin G., Koh C., Gervais-Bird J., Lapointe E., Froehlich U., Durand M., Gendron D., Brosseau J.-P., Thibault P., Lucier J.-F., Tremblay K., Prinos P., Wellinger R. J., Chabot B., Rancourt C., Elela S. A., Identification of alternative splicing markers for breast cancer. Cancer Research 2008 68 22 9525 9531 2-s2.0-56449105613 10.1158/0008-5472.CAN-08-1769
127. Lenos K., Grawenda A. M., Lodder K., Alternate splicing of the p53 inhibitor HDMX offers a superior prognostic biomarker than p53 mutation in human cancer. Cancer Research 2012 72 16 4074 4084
128. Kole R., Krainer A. R., Altman S., RNA therapeutics: beyond RNA interference and antisense oligonucleotides. Nature Reviews Drug Discovery 2012 11 2 125 140 2-s2.0-84856431819 10.1038/nrd3625
129. Bonnal S., Vigevani L., Valcárcel J., The spliceosome as a target of novel antitumour drugs. Nature Reviews. Drug Discovery 2012 11 11 847 859
130. Zammarchi F., De Stanchina E., Bournazou E., Supakorndej T., Martires K., Riedel E., Corben A. D., Bromberg J. F., Cartegni L., Antitumorigenic potential of STAT3 alternative splicing modulation. Proceedings of the National Academy of Sciences of the United States of America 2011 108 43 17779 17784 2-s2.0-80055072546 10.1073/pnas.1108482108
131. Corrionero A., Miñana B., Valcárcel J., Reduced fidelity of branch point recognition and alternative splicing induced by the anti-tumor drug spliceostatin A. Genes and Development 2011 25 5 445 459 2-s2.0-79952220808 10.1101/gad.2014311
132. Karni R., De Stanchina E., Lowe S. W., Sinha R., Mu D., Krainer A. R., The gene encoding the splicing factor SF2/ASF is a proto-oncogene. Nature Structural and Molecular Biology 2007 14 3 185 193 2-s2.0-33847630730 10.1038/nsmb1209
133. Fedorov O., Huber K., Eisenreich A., Filippakopoulos P., King O., Bullock A. N., Szklarczyk D., Jensen L. J., Fabbro D., Trappe J., Rauch U., Bracher F., Knapp S., Specific CLK inhibitors from a novel chemotype for regulation of alternative splicing. Chemistry and Biology 2011 18 1 67 76 2-s2.0-79251579303 10.1016/j.chembiol.2010.11.009
134. Chang W.-H., Liu T.-C., Yang W.-K., Lee C.-C., Lin Y.-H., Chen T.-Y., Chang J.-G., Amiloride modulates alternative splicing in leukemic cells and resensitizes Bcr-AblT315I mutant cells to imatinib. Cancer Research 2011 71 2 383 392 2-s2.0-78751562185 10.1158/0008-5472.CAN-10-1037
135. Chang J.-G., Yang D.-M., Chang W.-H., Chow L.-P., Chan W.-L., Lin H.-H., Huang H.-D., Chang Y.-S., Hung C.-H., Yang W.-K., Small molecule Amiloride modulates oncogenic RNA alternative splicing to devitalize human cancer cells. PLoS ONE 2011 6 6 2-s2.0-79958294217 10.1371/journal.pone.0018643 e18643
136. Pal S. K., Reckamp K., Yu H., Figlin R. A., Akt inhibitors in clinical development for the treatment of cancer. Expert Opinion on Investigational Drugs 2010 19 11 1355 1366 2-s2.0-77958509195 10.1517/13543784.2010.520701
137. Santarpia L., Lippman S. M., El-Naggar A. K., Targeting the MAPKRASRAF signaling pathway in cancer therapy. Expert Opinion on Therapeutic Targets 2012 16 1 103 119 2-s2.0-84855894652 10.1517/14728222.2011.645805
138. Zhang S., Yu D., Targeting Src family kinases in anti-cancer therapies: turning promise into triumph. Trends in Pharmacological Sciences 2012 33 3 122 128 2-s2.0-84857916018 10.1016/j.tips.2011.11.002